Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,636 | 503 | 99.9% |
| Education | $6.96 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,646 | 131 | $0 (2024) |
| ABBVIE INC. | $1,358 | 112 | $0 (2024) |
| Lilly USA, LLC | $981.81 | 68 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $686.76 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $567.59 | 33 | $0 (2024) |
| Lundbeck LLC | $244.67 | 13 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $229.03 | 16 | $0 (2023) |
| PFIZER INC. | $198.96 | 15 | $0 (2024) |
| Amgen Inc. | $165.85 | 10 | $0 (2024) |
| Esperion Therapeutics, Inc. | $154.37 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,329 | 145 | Novo Nordisk Inc ($461.05) |
| 2023 | $1,882 | 132 | Novo Nordisk Inc ($402.57) |
| 2022 | $1,762 | 111 | Novo Nordisk Inc ($447.93) |
| 2021 | $1,670 | 116 | Lilly USA, LLC ($340.28) |
All Payment Transactions
504 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Diabetes | ||||||
| 12/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Obesity | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Pulmonology | ||||||
| 10/29/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: VACCINES | ||||||
| 10/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $9.39 | General |
| 10/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: DIABETES | ||||||
| 09/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Diabetes Care | ||||||
| 09/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: VACCINES | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Pulmonology | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | COSELA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.84 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.57 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 160 | 1,173 | $80,364 | $48,467 |
| 2022 | 3 | 132 | 214 | $20,594 | $11,774 |
| 2021 | 7 | 216 | 255 | $34,629 | $16,760 |
| 2020 | 8 | 515 | 666 | $93,891 | $35,557 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 124 | 1,119 | $71,616 | $44,828 | 62.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 54 | $8,748 | $3,639 | 41.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 77 | 146 | $9,344 | $6,259 | 67.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 50 | $8,100 | $3,513 | 43.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 18 | 18 | $3,150 | $2,002 | 63.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 95 | $15,390 | $7,535 | 49.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 24 | 24 | $4,200 | $2,725 | 64.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 38 | 38 | $8,204 | $2,710 | 33.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 23 | 23 | $1,955 | $1,528 | 78.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 23 | $2,860 | $1,010 | 35.3% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 29 | 29 | $870.00 | $870.00 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $1,150 | $381.57 | 33.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 215 | 353 | $57,186 | $21,431 | 37.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 55 | 55 | $13,695 | $4,697 | 34.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 40 | 40 | $7,000 | $3,900 | 55.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 85 | 90 | $9,915 | $3,519 | 35.5% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 19 | 19 | $1,615 | $1,159 | 71.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 28 | 29 | $1,450 | $462.64 | 31.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 34 | 34 | $1,190 | $287.89 | 24.2% |
| 81003 | Automated urinalysis test | Office | 2020 | 39 | 46 | $1,840 | $100.82 | 5.5% |
About Hillary Bailey, DNP, APRN
Hillary Bailey, DNP, APRN is a Family healthcare provider based in Lake City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2017. The National Provider Identifier (NPI) number assigned to this provider is 1154869782.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hillary Bailey, DNP, APRN has received a total of $7,643 in payments from pharmaceutical and medical device companies, with $2,329 received in 2024. These payments were reported across 504 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,636).
As a Medicare-enrolled provider, Bailey has provided services to 1,023 Medicare beneficiaries, totaling 2,308 services with total Medicare billing of $112,558. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Lake City, FL
- Active Since 02/02/2017
- Last Updated 05/16/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1154869782
Products in Payments
- JARDIANCE (Drug) $642.48
- Ozempic (Drug) $583.30
- VRAYLAR (Drug) $573.42
- UBRELVY (Drug) $544.05
- Rybelsus (Drug) $485.69
- REXULTI (Drug) $351.69
- TRULICITY (Drug) $277.44
- Wegovy (Drug) $277.43
- FARXIGA (Drug) $267.50
- MOUNJARO (Drug) $244.45
- Kerendia (Drug) $229.03
- NURTEC ODT (Drug) $228.68
- EMGALITY (Drug) $165.90
- QULIPTA (Drug) $158.20
- BREZTRI (Drug) $157.48
- AIRSUPRA (Drug) $137.38
- NEXLETOL (Drug) $132.65
- VOQUEZNA (Drug) $130.93
- FASENRA (Biological) $124.40
- LEQVIO (Drug) $98.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lake City
Taily Alonso, Aprn, APRN
Family — Payments: $10,522
Spring Cramer, Aprn, APRN
Family — Payments: $7,009
Camilla Pace, Fnp, FNP
Family — Payments: $6,744
Elaina Williamson, Arnp, ARNP
Family — Payments: $3,620
Beth Henderson, Aprn, APRN
Family — Payments: $3,539
Dr. Samantha Smythe, Aprn, APRN
Family — Payments: $2,762